Century Therapeutics, Inc. (IPSC) stock
IPSCNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 8/30
$1.37−0.27 (-16.46%)
Close on Nov 17, 2026Market cap $248.07MP/E –Yield –
Century Therapeutics price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Century Therapeutics's price to sales ratio was 1.8× on Apr 30, 2026, against 7.1× a year earlier. Over the last 3 years it ranged from 0.4× to 130.8×, with a median of 31.8×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Apr 30, 2026 | 1.8× | +1.1 |
| 2025 | Dec 31, 2025 | 0.8× | −31.0 |
| 2024 | Dec 31, 2024 | 31.8× | −47.6 |
| 2023 | Dec 29, 2023 | 79.4× | – |
See a number that looks wrong?